Safety and tolerability of new-generation anti-obesity medications: a narrative review-Reference-Cited by-同舟云学术

Safety and tolerability of new-generation anti-obesity medications: a narrative review

Published:2018-02-08 Issue:2 Volume:130 Page:173-182
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Patel Dhiren K¹²,Stanford Fatima Cody³⁴⁵

Affiliation:

1. MCPHS University, School of Pharmacy, Boston, MA, USA

2. Endocrinology, VA Boston Healthcare System, Boston, MA, USA

3. Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA

4. Division of Endocrinology, Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA

5. Endocrinology, Harvard Medical School, Boston, MA, USA

Funder

Novo Nordisk

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2018.1435129

Reference90 articles.

1. WHO. Obesity: data and statistics. [cited 2017 Nov 17]. Available from: http://www.euro.who.int/en/health-topics/noncommunicable-diseases/obesity/data-and-statistics.

2. Obesity and Severe Obesity Forecasts Through 2030

3. Ogden CL, Carroll MD, Fryar CD, et al. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief. 2015:1–8. [cited 2017 Nov 17]. Available from: https://www.cdc.gov/nchs/data/databriefs/db219.pdf.

4. Annual Medical Spending Attributable To Obesity: Payer-And Service-Specific Estimates

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Naltrexone/Bupropion in Treatment of Binge Eating: A Systematic Review and Meta-Analysis;Psychiatry International;2024-07-02

2. Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD);Journal of Clinical & Translational Endocrinology;2024-06

3. What is the evidence regarding the safety of new obesity pharmacotherapies;International Journal of Obesity;2024-02-09

4. Biaryl carboxamide‐based peptidomimetics analogs as potential pancreatic lipase inhibitors for treating obesity;Archiv der Pharmazie;2024-01-22

5. Pharmacotherapy of obesity: State of the art and perspectives;Arhiv za farmaciju;2024